Innovative solutions to the greatest challenges in pharmaceutical development
The growth of biopharma, patient compliance issues and ever increasing regulatory requirements have encouraged us to adopt a drug delivery mind set from discovery through to production.
Every year we see innovation and breakthroughs at all levels of drug and formulation development. From big pharma, through the smaller biotechnology companies all the way to university research teams and spin outs.
The DDF Summit brings the most interesting studies and exciting technologies to you. This year there will be 4 dedicated streams focusing on Small Molecules, Biologics, Technology & Innovation and for the first-time Device Development.
You’ll find new technologies, concepts and case studies in areas such as…
• Less traditional delivery routes including nasal, ocular & subcutaneous
• Targeted and controlled release technologies and nanoparticles
• Increasing stability of amorphous solid dispersions
• QbD in biopharmaceutical development
• Formulation strategies for multiple injection dosing
• Oral delivery of peptides
• Continuous manufacturing and processing for improved efficiency
• User friendly technologies for improving patient convenience and compliance
• Regulatory strategies for combination products
• Drug stability and material selection in combination products
Venue: Maritim proArte Hotel Berlin
Date: 12 – 14 March 2018
Contact person: Josh Lowth (josh.lowth@markallengroup.com)Website:www.ddfevent.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.